Abstract
An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Current Genomics
Title: The Use of Microarrays to Study Childhood Developmental Brain Disorders
Volume: 3 Issue: 1
Author(s): C. Colantuoni, A. Comi, A. E. Purcell and J. Pevsner
Affiliation:
Keywords: Microarrays, Brain Disorders, pervasive devleopment disorder pdd, hyperactivity disorder adhd, obseeive-compulsive disorder ocd
Abstract: An estimated 9 to 22 % of the pediatric age group are affected by the extremely broad range of childhood neurological disorders, which includes autism and other pervasive developmental disorders (PDD). As with most all of the neurodevelopmental disorders, the PDD spectrum disorders demonstrate a tremendous degree of clinical, biochemical, and genetic heterogeneity. In the great majority of cases, the underlying molecular defects are not known and both diagnosis and appropriate treatment remain challenging. Gene expression profiling using DNA microarrays is a useful tool to characterize cellular samples from patients with childhood neurological disorders. There are two principal goals in the characterization of transcriptional changes in these disorders: 1) Accurate molecular diagnosis of disorders in the absence of clear clinical or biochemical diagnostic markers. Additionally, analysis of transcriptional patterns can be used to generate sub-classifications of individual disorders. 2) Identificat ion of cellular systems that are disrupted in the disorder. Changes in the expression of individual genes as well as functionally related groups of genes can delineate biochemical pathways that are perturbed in a disorder. Both of these goals are ultimately directed at the development of effective therapeutic strategies. This review describes recent advances in these areas, discussing issues relevant to the study of gene expression in pediatric neurodevelopmental disorders.
Export Options
About this article
Cite this article as:
Colantuoni C., Comi A., Purcell E. A. and Pevsner J., The Use of Microarrays to Study Childhood Developmental Brain Disorders, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350660
DOI https://dx.doi.org/10.2174/1389202023350660 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods
Current Pharmaceutical Design The Therapeutic Value of Natural Agents to Treat miRNA Targeted Breast Cancer in African-American and Caucasian-American Women
Current Drug Targets Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)
Current Pharmaceutical Design Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy Sarcoidosis and Sarcoid Reactions in Endometrial Cancer Cases Masquerading Advanced Stage Malignancy
Current Women`s Health Reviews Role of the Renin-Angiotensin System in Gynecologic Cancers
Current Cancer Drug Targets Contemporary Review of Drugs Used to Treat Obesity
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Thematic Issue: Chemoresistance in Gynecologic Cancers)
Current Cancer Therapy Reviews Drug Repurposing in Anticancer Reagent Development
Combinatorial Chemistry & High Throughput Screening Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Regulation of Gene Expression by Progesterone in Cancer Cells: Effects on Cyclin D1, EGFR and VEGF
Mini-Reviews in Medicinal Chemistry Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review
Current Medicinal Chemistry A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV
Current Topics in Medicinal Chemistry DLEU1: A Functional Long Noncoding RNA in Tumorigenesis
Current Pharmaceutical Design Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design Applications of Metabonomics in Pesticide Toxicology
Current Drug Metabolism